Literature DB >> 7681229

Inhibition of the multidrug efflux pump in isolated hepatocyte couplets by immunosuppressants FK506 and cyclosporine.

N Takeguchi1, K Ichimura, M Koike, W Matsui, T Kashiwagura, K Kawahara.   

Abstract

Fluorescence image analysis of isolated rat hepatocyte couplets, which retain a bile canaliculus between them, has shown the presence of transport systems for the bile acid and non-bile acid organic anion in the canalicular membrane. The cells also transported Fura-2 and BCECF, which are fluorescent indicators of intracellular Ca2+ and H+ concentrations, respectively, into the canaliculus. Both Fura-2 and BCECF transports were inhibited by progesterone, verapamil, vinblastine, and daunomycin, indicating that the transports are due to a multidrug efflux pump (P-glycoprotein) in the canalicular membrane. Interestingly, the transport by the multidrug efflux pump was inhibited by immunosuppressants FK506 (tacrolimus) and cyclosporine, their half-maximal inhibitory concentrations in the cell suspension being 10 microM and 0.6 microM, respectively. In contrast, the reported immunosuppressive potency of FK506 is 10- to 100-fold that of cyclosporine. Inhibition by immunosuppressants of the multidrug efflux pump, which is a transporter of cytotoxic and other drugs and present in normal human tissues--such as kidney, liver, the blood-brain barrier, and colon--may, at least partly, explain side effects caused by cyclosporine in these tissues of transplant recipients. FK506 at its clinical concentrations may not inhibit the multidrug efflux pump.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7681229     DOI: 10.1097/00007890-199303000-00033

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  10 in total

1.  [Case of inflammatory vasculopathy and encephalopathy caused by treatment with tacrolimus].

Authors:  Adrian Ringelstein; Katja Bongs; Burkhard Sorge-Hädicke; Peter Berlit
Journal:  Nervenarzt       Date:  2005-04       Impact factor: 1.214

2.  Functional heterogeneity of human tissue-resident memory T cells based on dye efflux capacities.

Authors:  Brahma V Kumar; Radomir Kratchmarov; Michelle Miron; Dustin J Carpenter; Takashi Senda; Harvey Lerner; Amy Friedman; Steven L Reiner; Donna L Farber
Journal:  JCI Insight       Date:  2018-11-15

Review 3.  Drug interactions with patient-controlled analgesia.

Authors:  Jorn Lotsch; Carsten Skarke; Irmgard Tegeder; Gerd Geisslinger
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

4.  Effect of pharmacological modulation of liver P-glycoproteins on cyclosporin A biliary excretion and cholestasis: a study in isolated perfused rat liver.

Authors:  M D Delle Monache; A Gigliozzi; A Benedetti; L Marucci; A Bini; C Francia; E Papa; E Di Cosimo; F Fraioli; A M Jezequel; D Alvaro
Journal:  Dig Dis Sci       Date:  1999-11       Impact factor: 3.199

5.  Potential effect of cyclosporin A in formation of cholesterol gallstones in pediatric liver transplant recipients.

Authors:  S Cao; K Cox; S S So; W Berquist; S P Lee; W G Haigh; W Concepcion; H Monge; C O Esquivel
Journal:  Dig Dis Sci       Date:  1997-07       Impact factor: 3.199

6.  P-glycoprotein-dependent disposition kinetics of tacrolimus: studies in mdr1a knockout mice.

Authors:  K Yokogawa; M Takahashi; I Tamai; H Konishi; M Nomura; S Moritani; K Miyamoto; A Tsuji
Journal:  Pharm Res       Date:  1999-08       Impact factor: 4.200

7.  Modulation of Multidrug Resistance in Cancer by Immunosuppresive Agents. Preclinical Studies.

Authors:  Adorján Aszalos
Journal:  Pathol Oncol Res       Date:  1995       Impact factor: 3.201

8.  Relevance of p-glycoprotein for the enteral absorption of cyclosporin A: in vitro-in vivo correlation.

Authors:  G Fricker; J Drewe; J Huwyler; H Gutmann; C Beglinger
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

9.  Uptake and metabolism of serotonin by ependymal primary cultures.

Authors:  Stephan Verleysdonk; Bernd Hamprecht; Mirna Rapp; John Wellard
Journal:  Neurochem Res       Date:  2004-09       Impact factor: 3.996

Review 10.  Mechanisms of clinically relevant drug interactions associated with tacrolimus.

Authors:  Uwe Christians; Wolfgang Jacobsen; Leslie Z Benet; Alfonso Lampen
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.